This event has passed.
RNA Therapeutics 2025
Register for the event
This event has passed.
RNA Therapeutics 2025
The RNA therapeutics industry has grown exponentially in recent years, largely attributed to the advancements in CRISPR RNA-editing technologies, and increased exposure of RNA vaccines following the COVID-19 pandemic. This upward trajectory is expected to continue, with 131 candidate therapies in clinical trials as of January 2024.
Bachem participates in this event.
See who is attending from Bachem
